The Technical Analyst
Select Language :
Paxman AB (publ) [PAX.ST]

Exchange: STO Sector: Healthcare Industry: Medical Devices

Paxman AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals

Paxman AB (publ) is listed at the  Exchange

0.64% SEK47.00

America/New_York / 31 mai 2024 @ 11:24


Paxman AB (publ): Main Fundamentals PE comparison

Paxman AB (publ) PE Comparison

Report updated: 2024-06-02 @ 02:11
Comp Ticker PE
Bactiguard Holding AB BACTI-B.ST -58.020
Paxman AB (publ) PAX.ST -41.100
Sedana Medical AB (publ) SEDANA.ST -35.020
Mentice AB (publ) MNTC.ST -34.760
SpectraCure AB (publ) SPEC.ST -27.540
ScandiDos AB (publ) SDOS.ST -15.990
Iconovo AB (publ) ICO.ST -14.500
Arcoma AB ARCOMA.ST -10.100
Duearity AB (publ) DEAR.ST -9.570
Episurf Medical AB (publ) EPIS-B.ST -8.240
Dignitana AB (publ) DIGN.ST -8.140
Senzime AB (publ) SEZI.ST -8.010
SciBase Holding AB (publ) SCIB.ST -5.170
GPX Medical AB (publ) GPXMED.ST -5.170
OssDsign AB (publ) OSSD.ST -3.550
Pharmacolog i Uppsala AB PHLOG-B.ST -2.650
Luxbright AB (publ) LXB.ST -2.490
Acarix AB (publ) ACARIX.ST -0.900
Qlife Holding AB (publ) QLIFE.ST -0.660
Clinical Laserthermia CLS-B.ST -0.620
S2Medical AB (publ) S2M.ST -0.540
Hemcheck Sweden AB (publ) HEMC.ST -0.390
IRRAS AB (publ) IRRAS.ST -0.260
Boule Diagnostics AB BOUL.ST 16.460
Getinge AB (publ) GETI-B.ST 22.730
Stille AB STIL.ST 22.840
ADDvise Group AB (publ) ADDV-B.ST 25.480
ADDvise Group AB (publ) ADDV-A.ST 25.900
CellaVision AB (publ) CEVI.ST 42.030
Vitrolife AB (publ) VITR.ST 90.780
C-Rad AB (publ) CRAD-B.ST 97.200
BICO Group AB (publ) BICO.ST 158.430
Integrum AB (publ) INTEG-B.ST 181.840
Xvivo Perfusion AB (publ) XVIVO.ST 222.280

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.